2008 FIP congress supplement out now
The Pharmaceutical Journal’s extended coverage of 2008’s FIP congress is published in a 40-page supplement, available now writes Lin-Nam Wang
The Journal’s extended coverage of 2008’s FIP congress is published in a 40-page supplement, available now writes Lin-Nam Wang
A team of 14 pharmacists acted as reporters for The Pharmaceutical Journal at the 68th congress of the International Pharmaceutical Federation (FIP), which took place in Basel, Switzerland, from 29 August to 4 September 2008.
Their reports from the World Congress of Pharmacy and Pharmaceutical Sciences are collated in a supplement (pictured right), which is now available.
The FIP secretariat will be distributing copies from its headquarters in the Netherlands to FIP members who attended the congress.
Readers who are interested in reading about what went on are invited to request their own personal copy of the supplement (see Panel).
The supplement is available on PJ Online.
How to request a copy
The supplement begins with a report of the address of FIP president Kamal Midha, which focused on the federation’s strategic plan. Dr Midha told the congress that work had already begun to place FIP on the global map of medicines and healthcare through the engagement of all stakeholders and gave examples of projects in Uganda, Vietnam, Uruguay and Indonesia. He also described a partnership between FIP and the School of Pharmacy, University of London, to launch a collaborating centre for pharmacy and health.
A report of the congress keynote lecture, which focused on how public-private partnerships are aiding drug discovery for neglected diseases, also features. In his lecture, William Charman, professor of pharmaceutics at Monash University, Melbourne, Australia, described how these partnerships have been used to develop new antimalarials.
The theme of the 2008 congress was “Re-engineering pharmacy practice in a changing world” and the practice symposia covered how pharmacists can work to improve therapeutic outcomes and patient care and what the future might hold in terms of workforce, competence and education.
In addition, the congress hosted a strong science programme and reports include:
- What is happening in the world of vaccines (including mucosal delivery of vaccines against HIV)
- Advances in targeted drug delivery (including delivery across the placenta)
- The story behind the discovery of drug-grapefruit interactions
- How research can best be moved from the bench to the bedside
- The growing importance of biosimilars (and why pharmacists need to understand the background to their development)
The question “are pharmacy degrees failing industry and is it time for a new approach?” was discussed in a joint session held by the Industrial Pharmacy Section and the Academic Pharmacy Section, and other academic sessions looked at design to promote life-long learning and higher level practice.
The patient was the focus of sessions on individualised medicine, adherence technology, control of health records, safety and patient information, and accounts of these are given in the supplement.
Sessions giving updates on the fight against counterfeit medicines and HIV (FIP’s “Recommendations for pharmacy management and the dispensing of antiretroviral medicines in resource limited settings” were launched during the congress) and suggesting solutions for accessing medicines in low income countries are also included.
2009’s congress will take place in Istanbul, Turkey.
Citation: The Pharmaceutical Journal URI: 10039217
Recommended from Pharmaceutical Press
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00Buy now
Pharmacy Registration Assessment Questions features over 400 closed book and calculation questions. With the registration exam having gone through a complete transformation in 2016, this volume has been developed around the new General Pharmaceutical Council (GPhC) guidelines.
Commonly known as the Orange Guide, this book is an essential reference for all involved in the manufacture or distribution of medicines in Europe.£82.00Buy now